Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 44, Issue 7, Pages 673-683
Publisher
Wiley
Online
2016-08-09
DOI
10.1111/apt.13754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 692 Drug-Level Based Dosing Versus Symptom-Based Dose Adaptation in Patients With Crohn's Disease: A Prospective, Randomized Multicenter Study (TAILORIX)
- (2016) Geert R. D'Haens et al. GASTROENTEROLOGY
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Factors Associated with Durable Response to Infliximab in Crohnʼs Disease 5 Years and Beyond
- (2015) Pascal Juillerat et al. INFLAMMATORY BOWEL DISEASES
- Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays
- (2015) Thomas Van Stappen et al. THERAPEUTIC DRUG MONITORING
- A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease
- (2014) B. G. Levesque et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
- (2014) Omoniyi J. Adedokun et al. GASTROENTEROLOGY
- Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
- (2014) Freddy Cornillie et al. GUT
- The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
- (2014) Niels Vande Casteele et al. GUT
- Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD
- (2014) Madeline Therese Frederiksen et al. INFLAMMATORY BOWEL DISEASES
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Targeting TNF-α for the treatment of inflammatory bowel disease
- (2013) Thomas Billiet et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ten Years of Infliximab for Crohn’s Disease
- (2013) Emma J. Eshuis et al. INFLAMMATORY BOWEL DISEASES
- C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
- (2012) W. Reinisch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
- (2012) N. Vande Casteele et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
- (2012) Pauliina Molander et al. INFLAMMATORY BOWEL DISEASES
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
- (2010) Matthieu Allez et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the Performance of Prediction Models
- (2009) Ewout W. Steyerberg et al. EPIDEMIOLOGY
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now